vs
Side-by-side financial comparison of FIRST MID BANCSHARES, INC. (FMBH) and HARROW, INC. (HROW). Click either name above to swap in a different company.
HARROW, INC. is the larger business by last-quarter revenue ($89.1M vs $88.2M, roughly 1.0× FIRST MID BANCSHARES, INC.). FIRST MID BANCSHARES, INC. runs the higher net margin — 26.8% vs 7.4%, a 19.4% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 3.4%). FIRST MID BANCSHARES, INC. produced more free cash flow last quarter ($124.0M vs $8.1M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 5.0%).
First Mid Bancshares Inc. is a U.S.-headquartered regional financial services holding company. It provides full-range retail and commercial banking products, wealth management, insurance solutions, and agricultural financing, mainly serving individual consumers, small and medium-sized enterprises, and agricultural clients across multiple Midwestern states including Illinois, Missouri, and Indiana.
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
FMBH vs HROW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $88.2M | $89.1M |
| Net Profit | $23.7M | $6.6M |
| Gross Margin | — | 79.3% |
| Operating Margin | 34.0% | 17.5% |
| Net Margin | 26.8% | 7.4% |
| Revenue YoY | 3.4% | 33.3% |
| Net Profit YoY | 23.5% | -2.2% |
| EPS (diluted) | $0.98 | $0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $88.2M | $89.1M | ||
| Q3 25 | $89.3M | $71.6M | ||
| Q2 25 | $87.5M | $63.7M | ||
| Q1 25 | $84.3M | $47.8M | ||
| Q4 24 | $85.3M | $66.8M | ||
| Q3 24 | $80.6M | $49.3M | ||
| Q2 24 | $79.2M | $48.9M | ||
| Q1 24 | $79.9M | $34.6M |
| Q4 25 | $23.7M | $6.6M | ||
| Q3 25 | $22.5M | $1.0M | ||
| Q2 25 | $23.4M | $5.0M | ||
| Q1 25 | $22.2M | $-17.8M | ||
| Q4 24 | $19.2M | $6.8M | ||
| Q3 24 | $19.5M | $-4.2M | ||
| Q2 24 | $19.7M | $-6.5M | ||
| Q1 24 | $20.5M | $-13.6M |
| Q4 25 | — | 79.3% | ||
| Q3 25 | — | 75.3% | ||
| Q2 25 | — | 74.5% | ||
| Q1 25 | — | 67.5% | ||
| Q4 24 | — | 78.8% | ||
| Q3 24 | — | 75.6% | ||
| Q2 24 | — | 74.4% | ||
| Q1 24 | — | 69.5% |
| Q4 25 | 34.0% | 17.5% | ||
| Q3 25 | 32.2% | 20.6% | ||
| Q2 25 | 34.4% | 17.9% | ||
| Q1 25 | 33.4% | -23.5% | ||
| Q4 24 | 29.7% | 19.3% | ||
| Q3 24 | 31.5% | 2.7% | ||
| Q2 24 | 33.7% | 3.1% | ||
| Q1 24 | 33.7% | -20.0% |
| Q4 25 | 26.8% | 7.4% | ||
| Q3 25 | 25.2% | 1.4% | ||
| Q2 25 | 26.8% | 7.8% | ||
| Q1 25 | 26.3% | -37.2% | ||
| Q4 24 | 22.5% | 10.1% | ||
| Q3 24 | 24.2% | -8.6% | ||
| Q2 24 | 24.9% | -13.2% | ||
| Q1 24 | 25.6% | -39.2% |
| Q4 25 | $0.98 | $0.20 | ||
| Q3 25 | $0.94 | $0.03 | ||
| Q2 25 | $0.98 | $0.13 | ||
| Q1 25 | $0.93 | $-0.50 | ||
| Q4 24 | $0.81 | $0.19 | ||
| Q3 24 | $0.81 | $-0.12 | ||
| Q2 24 | $0.82 | $-0.18 | ||
| Q1 24 | $0.86 | $-0.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $72.9M |
| Total DebtLower is stronger | $354.5M | $250.0M |
| Stockholders' EquityBook value | $958.7M | $52.4M |
| Total Assets | $8.0B | $399.5M |
| Debt / EquityLower = less leverage | 0.37× | 4.77× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $72.9M | ||
| Q3 25 | — | $74.3M | ||
| Q2 25 | — | $53.0M | ||
| Q1 25 | — | $66.7M | ||
| Q4 24 | — | $47.2M | ||
| Q3 24 | — | $72.6M | ||
| Q2 24 | — | $71.0M | ||
| Q1 24 | — | $76.0M |
| Q4 25 | $354.5M | $250.0M | ||
| Q3 25 | — | $347.2M | ||
| Q2 25 | — | $250.6M | ||
| Q1 25 | — | $256.9M | ||
| Q4 24 | — | $262.7M | ||
| Q3 24 | — | $230.7M | ||
| Q2 24 | — | $236.3M | ||
| Q1 24 | — | $243.4M |
| Q4 25 | $958.7M | $52.4M | ||
| Q3 25 | $932.2M | $47.0M | ||
| Q2 25 | $894.1M | $49.7M | ||
| Q1 25 | $870.9M | $56.5M | ||
| Q4 24 | $846.4M | $69.7M | ||
| Q3 24 | $858.5M | $58.0M | ||
| Q2 24 | $813.6M | $58.5M | ||
| Q1 24 | $798.0M | $60.6M |
| Q4 25 | $8.0B | $399.5M | ||
| Q3 25 | $7.8B | $363.1M | ||
| Q2 25 | $7.7B | $345.0M | ||
| Q1 25 | $7.6B | $364.2M | ||
| Q4 24 | $7.5B | $389.0M | ||
| Q3 24 | $7.6B | $351.5M | ||
| Q2 24 | $7.6B | $306.6M | ||
| Q1 24 | $7.7B | $295.5M |
| Q4 25 | 0.37× | 4.77× | ||
| Q3 25 | — | 7.39× | ||
| Q2 25 | — | 5.05× | ||
| Q1 25 | — | 4.55× | ||
| Q4 24 | — | 3.77× | ||
| Q3 24 | — | 3.98× | ||
| Q2 24 | — | 4.04× | ||
| Q1 24 | — | 4.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $130.9M | $8.4M |
| Free Cash FlowOCF − Capex | $124.0M | $8.1M |
| FCF MarginFCF / Revenue | 140.6% | 9.1% |
| Capex IntensityCapex / Revenue | 7.8% | 0.4% |
| Cash ConversionOCF / Net Profit | 5.53× | 1.27× |
| TTM Free Cash FlowTrailing 4 quarters | $207.9M | $43.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $130.9M | $8.4M | ||
| Q3 25 | $33.0M | $16.6M | ||
| Q2 25 | $7.7M | $-803.0K | ||
| Q1 25 | $47.9M | $19.7M | ||
| Q4 24 | $124.4M | $-17.8M | ||
| Q3 24 | $33.1M | $3.0M | ||
| Q2 24 | $24.0M | $-2.7M | ||
| Q1 24 | $29.0M | $-4.6M |
| Q4 25 | $124.0M | $8.1M | ||
| Q3 25 | $31.9M | $16.4M | ||
| Q2 25 | $6.0M | $-969.0K | ||
| Q1 25 | $46.0M | $19.5M | ||
| Q4 24 | $119.5M | $-18.3M | ||
| Q3 24 | $32.0M | $2.3M | ||
| Q2 24 | $22.9M | $-3.1M | ||
| Q1 24 | $27.6M | $-4.7M |
| Q4 25 | 140.6% | 9.1% | ||
| Q3 25 | 35.8% | 22.9% | ||
| Q2 25 | 6.8% | -1.5% | ||
| Q1 25 | 54.5% | 40.8% | ||
| Q4 24 | 140.0% | -27.4% | ||
| Q3 24 | 39.7% | 4.8% | ||
| Q2 24 | 28.9% | -6.3% | ||
| Q1 24 | 34.5% | -13.6% |
| Q4 25 | 7.8% | 0.4% | ||
| Q3 25 | 1.2% | 0.3% | ||
| Q2 25 | 2.0% | 0.3% | ||
| Q1 25 | 2.3% | 0.4% | ||
| Q4 24 | 5.8% | 0.8% | ||
| Q3 24 | 1.4% | 1.2% | ||
| Q2 24 | 1.4% | 0.7% | ||
| Q1 24 | 1.9% | 0.3% |
| Q4 25 | 5.53× | 1.27× | ||
| Q3 25 | 1.47× | 16.26× | ||
| Q2 25 | 0.33× | -0.16× | ||
| Q1 25 | 2.16× | — | ||
| Q4 24 | 6.49× | -2.62× | ||
| Q3 24 | 1.70× | — | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 1.42× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
